Infliximab for relapsing neurosarcoidosis recurring after kidney transplantation: a case report.
Nicolas HansetMawufemo Yawovi TseviThierry DuprezAdrian IvanoiuArnaud DevresseNathalie DemoulinNada KanaanPublished in: Acta clinica Belgica (2019)
Neurological involvement of sarcoidosis is a rare condition, and its occurrence in the context of transplantation is exceptional. Moreover, treatment can be challenging. We report the unusual case of a patient transplanted with a kidney for end-stage renal disease secondary to sarcoidosis who experienced a neurological recurrence of the disease under immunosuppressive treatment, translating in behavioural aggressiveness, social withdrawal and weight loss. He relapsed thrice under corticosteroids but responded finally to infliximab. This case highlights the potential of sarcoidosis to recur neurologically after kidney transplantation despite immunosuppressive treatment. Also, treatment of relapsing neurosarcoidosis can be challenging and may benefit from TNF-α blockers.
Keyphrases
- weight loss
- multiple sclerosis
- bariatric surgery
- stem cells
- acute myeloid leukemia
- risk assessment
- chronic kidney disease
- mesenchymal stem cells
- body mass index
- type diabetes
- combination therapy
- blood brain barrier
- diffuse large b cell lymphoma
- smoking cessation
- cell therapy
- cerebral ischemia
- brain injury
- human health